Y-mAbs Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Y-mAbs Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2019 to Q2 2024.
  • Y-mAbs Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2024 was $1.38M, a 0.15% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.38M -$2K -0.15% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.26M -$389K -23.7% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.52M -$384K -20.1% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $1.75M -$625K -26.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.38M -$1.25M -47.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.64M -$1.69M -50.7% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.91M -$2.07M -52% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $2.38M -$354K -13% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $2.63M -$652K -19.9% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $3.33M -$484K -12.7% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $3.97M -$404K -9.23% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.73M -$2.17M -44.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $3.28M +$887K +37.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.82M +$1.25M +48.6% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $4.38M +$1.61M +58.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $4.9M +$1.95M +66.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.39M -$768K -24.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $2.57M -$778K -23.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $2.76M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $2.95M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $3.16M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $3.35M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.